Impact of Parkinson's disease and levodopa on resting state functional connectivity related to speech prosody control

Parkinsonism Relat Disord. 2016 Jan:22 Suppl 1:S52-5. doi: 10.1016/j.parkreldis.2015.09.006. Epub 2015 Sep 3.

Abstract

Background: Impaired speech prosody is common in Parkinson's disease (PD). We assessed the impact of PD and levodopa on MRI resting-state functional connectivity (rs-FC) underlying speech prosody control.

Methods: We studied 19 PD patients in the OFF and ON dopaminergic conditions and 15 age-matched healthy controls using functional MRI and seed partial least squares correlation (PLSC) analysis. In the PD group, we also correlated levodopa-induced rs-FC changes with the results of acoustic analysis.

Results: The PLCS analysis revealed a significant impact of PD but not of medication on the rs-FC strength of spatial correlation maps seeded by the anterior cingulate (p = 0.006), the right orofacial primary sensorimotor cortex (OF_SM1; p = 0.025) and the right caudate head (CN; p = 0.047). In the PD group, levodopa-induced changes in the CN and OF_SM1 connectivity strengths were related to changes in speech prosody.

Conclusions: We demonstrated an impact of PD but not of levodopa on rs-FC within the brain networks related to speech prosody control. When only the PD patients were taken into account, the association between treatment-induced changes in speech prosody and changes in rs-FC within the associative striato-prefrontal and motor speech networks was found.

Keywords: Acoustic; Caudate nucleus; Dopaminergic; Functional connectivity; Levodopa; Motor speech network; Parkinson's disease; Resting state; Speech prosody; fMRI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Brain / drug effects
  • Brain / metabolism*
  • Humans
  • Levodopa / pharmacology
  • Levodopa / therapeutic use*
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Nerve Net / drug effects
  • Nerve Net / metabolism*
  • Neural Pathways / drug effects
  • Neural Pathways / metabolism
  • Parkinson Disease / diagnosis
  • Parkinson Disease / drug therapy
  • Parkinson Disease / metabolism*
  • Rest / physiology*
  • Speech / drug effects
  • Speech / physiology*
  • Speech Disorders / diagnosis
  • Speech Disorders / drug therapy
  • Speech Disorders / metabolism

Substances

  • Levodopa